Since peripheral blood B cells of tumor bearing HNSCC patients also expressed decreased levels of the cytotoxic TNFSF ligands TNF, LT-β, FasL and TRAIL, we examined whether HNSCC patient B cells displayed diminished tumoricidal activity (Figures 3C, D and Supplementary Figure 6). The gene discussed is TNF; the disease is neoplasm.